Alteration of Fibrous Capsule Formation by Use of Immunomodulation

Aesthetic Surgery Journal

Volumn 18, Issue 5, 1998, Pages 346-352

  Miller III, Archibald S ^a   Tarpley, Sharon Kaye ^a   Willard, Virgil V ^a   Reynolds, Gary D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0011041067     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1016/S1090-820X(98)70090-1     Document Type: Article

References (18)

1. Brownstein M.L., and Owsley Jr. J.Q. Augmentation mammaplasty: a survey of the major complications. In: Owsley Jr. J.Q., and Peterson R.A. (Eds). Symposium aesthetic surgery of the breast (1978), CV Mosby, St. Louis 267-271
2. De Cholnoky T. Augmentation mammaplasty: survey of complications in 10,941 patients by 265 surgeons. Plast Reconstr Surg 45 (1970) 573-577
3. Hipps C.J., Raju D.R., and Straith R.E. Influence of some operative and postoperative factors on capsular contracture around breast prostheses. Plast Reconstr Surg 61 (1978) 384-389
4. Schmidt G.H. Mammary implant shell failure. Ann Plast Surg 5 (1980) 369-371
5. Gayou R., and Rudolph R. Capsular contraction around silicone mammary prostheses. Ann Plast Surg 2 (1979) 62-71
6. Burkhardt B.R., Fried M., Schnur P.L., and Tofield J.J. Capsules, infection and intraluminal antibiotics. Plast Reconstr Surg 68 (1981) 43-49
7. Asplund O. Capsular contracture in silicone gel and saline filled implants after reconstruction. Plast Reconstr Surg 73 (1984) 270-275
8. Rodes N.D., McEntire J.E., Dunn P.A., et al. Phase I clinical studies with lymphoblastoid lymphokine preparations from the RPM I 1788 cell line. KAHNA, Hill No: human lymphokines: biological immune response modifiers (1982), New York Academic Press 699-730
9. Thomson A.W., and Cameron I.D. Immune suppression with cyclosporine A-optimism and caution. Scot Med J 26 (1981) 139-144
10. Kostakis A.J., White D.J.G., and Calne R.Y. Prolongation of rat heart allograft survival by cyclosporine-A. IRCS J Med Sci 5 (1977) 595-600
11. Muller J., Botzenhardt U., and Lemmel E.M. Studies on the mechanism of PMN activation. III. By lymphokines. Blut 46 (1983) 155-159
12. Panem S. The emergent importance of lymphokines. JAMA 249 (1983) 166-167
13. Rola-Plezccynski M., Lieu H., Hamel J., and LeMaire I. Stimulated human lymphocytes produced a soluble factor which inhibits fibroblast migration. Cell Immunol 74 (1982) 104-110
14. Thomson A.W., Moon D.K., Geczy C.L., and Nelson D.S. Cyclosporine-A inhibits lymphokine production but not the responses of macrophages to lymphokines. Immunol 48 (1983) 291-299
15. Leapman S.B., Strong D.M., Filo R.S., Smith E.J., and Brandt G.L. Cyclosporine-A prevents the appearance of cell surface "activation" antigens. Transplantation 34 (1982) 94-95
16. Szamel M., Berger P., and Resch K. Inhibition of T-lymphocyte activation by plasma membrane phospholipid metabolism. J Immunol 136 (1986) 264-269
17. Gunby P. Unusual aspects of cyclosporine-A's efficacy. JAMA 248 (1982) 1801-1803
18. Lilla J.A., and Visanges L.M. Long-term study of reactions to various silicone breast implants in rabbits. Plast Reconstr Surg 57 (1976) 637-649